you are here: Home News Nifty Pharma

Nifty Pharma

Divi's Labs, Lupin, other pharma stocks rise up to 4%; here's why HDFC Securities says sector looks 'attractive'
Pharma stocks jump up to 5% after US Senate passes Biosecure Act: Check top gainers
Pharma index snaps four-day rally as Dr Reddy's, Biocon, other shares slide up to 2 percent: Factors at play
Pharma stocks fall up to 3% after Trump promises to significantly cut drug prices in US
Pharma stocks slump as Trump shoots letters to 17 global drug majors seeking lower prices
Pharma stocks in green even as Trump threatens 200% tariffs; Lupin, Biocon lead gains
Nifty Pharma sole sectoral gainer as investors await clarity on Trump tariffs; Ajanta Pharma, Ipca Labs lead gains
Dr Reddy's, Laurus Labs, other pharma stocks jump up to 3% amid bullish brokerage calls, other triggers
Why generic pharma may dodge hit even as Trump revives drug pricing order
Nifty Pharma recovers, Asian drugmakers shares tumble as Trump to slash US drug prices
Nifty Pharma crashes 3% as tariff fears spook investors; Biocon, IPCA Labs settle 6% lower
Risk of high reciprocal tariffs on domestic pharma products is low, says CLSA
Trump promises 'never-seen-before' pharma tariffs soon; Nifty Pharma cracks 4.5%, IPCA Labs, Lupin sink 6%
Lupin, Dr Reddy's, other pharma stocks fall on Trump's 25% tariff plans
Nifty Pharma emerges as top sectoral gainer; US generics players could benefit from Trump's tariffs
Pharma stocks buck weak market; Dr Reddy's Labs, Cipla, Lupin up 1-4%
Nifty Pharma climbs to all-time high; rises 10% in past one month
Market tanks but Dow Trend scanner indicates strength in these stocks; Check if you own any
Budget to budget: Realty and PSU stocks shine; here's how various sectoral indices fared
Pharma stocks rally up to 8% to 52-week highs amid rise in fresh Covid cases
Sensex, Nifty rally break amid profit-booking, defensive plays the favourite
Sun Pharma market cap breezes past Rs 3 lakh crore, stock hits 52-week high
Nifty Pharma scales record highs, rises in 14 out of 17 straight sessions
Strong pharma Q2 earnings lift Nifty Pharma index up 6% in seven straight sessions
Mixed day for pharma; Ipca Labs soars 7%, Laurus Labs tanks 10%

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Nifty Pharma

Divi's Labs, Lupin, other pharma stocks rise up to 4%; here's why HDFC Securities says sector looks 'attractive'

Pharma stocks jump up to 5% after US Senate passes Biosecure Act: Check top gainers

Pharma index snaps four-day rally as Dr Reddy's, Biocon, other shares slide up to 2 percent: Factors at play

Pharma stocks fall up to 3% after Trump promises to significantly cut drug prices in US

Pharma stocks slump as Trump shoots letters to 17 global drug majors seeking lower prices

Pharma stocks in green even as Trump threatens 200% tariffs; Lupin, Biocon lead gains

Nifty Pharma sole sectoral gainer as investors await clarity on Trump tariffs; Ajanta Pharma, Ipca Labs lead gains

Dr Reddy's, Laurus Labs, other pharma stocks jump up to 3% amid bullish brokerage calls, other triggers

Why generic pharma may dodge hit even as Trump revives drug pricing order

Nifty Pharma recovers, Asian drugmakers shares tumble as Trump to slash US drug prices

Nifty Pharma crashes 3% as tariff fears spook investors; Biocon, IPCA Labs settle 6% lower

Risk of high reciprocal tariffs on domestic pharma products is low, says CLSA

Trump promises 'never-seen-before' pharma tariffs soon; Nifty Pharma cracks 4.5%, IPCA Labs, Lupin sink 6%

Lupin, Dr Reddy's, other pharma stocks fall on Trump's 25% tariff plans

Nifty Pharma emerges as top sectoral gainer; US generics players could benefit from Trump's tariffs

Pharma stocks buck weak market; Dr Reddy's Labs, Cipla, Lupin up 1-4%

Nifty Pharma climbs to all-time high; rises 10% in past one month

Market tanks but Dow Trend scanner indicates strength in these stocks; Check if you own any

Budget to budget: Realty and PSU stocks shine; here's how various sectoral indices fared

Pharma stocks rally up to 8% to 52-week highs amid rise in fresh Covid cases

Sensex, Nifty rally break amid profit-booking, defensive plays the favourite

Sun Pharma market cap breezes past Rs 3 lakh crore, stock hits 52-week high

Nifty Pharma scales record highs, rises in 14 out of 17 straight sessions

Strong pharma Q2 earnings lift Nifty Pharma index up 6% in seven straight sessions

Mixed day for pharma; Ipca Labs soars 7%, Laurus Labs tanks 10%